12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Friday. Notable gainers include Venus Concept (VERO), Asensus Surgical (ASXC), American Oncology Network (AONC), Anebulo Pharmaceuticals (ANEB), IN8bio (INAB), and Geron (GERN). On the losing side, Biomea Fusion (BMEA), Scinai Immunotherapeutics (SCNI), Seres Therapeutics (MCRB), Concord Medical Services (CCM), Arcturus Therapeutics (ARCT), and ENDRA Life Sciences (NDRA) saw declines.
June 07, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anebulo Pharmaceuticals shares rose 29.33% to $2.8, with a market value of $72.6 million.
The significant price increase indicates positive market sentiment or news.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
American Oncology Network shares rose 29.41% to $2.2, with a market value of $22.4 million.
The notable price increase suggests positive investor sentiment or news.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Asensus Surgical stock moved up by 41.22% to $0.33, with a market value of $90.3 million.
The substantial price increase indicates positive market reaction, possibly due to favorable news or developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Geron stock rose 21.07% to $4.71, with a market value of $2.7 billion.
The significant price increase indicates strong positive sentiment or news impacting the stock.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
IN8bio stock increased by 22.12% to $1.38, with a market value of $60.8 million.
The price increase suggests positive investor sentiment or news.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Venus Concept shares rose 87.9% to $1.1, with a market cap of $7.0 million.
The significant price increase suggests strong positive sentiment or news impacting the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Arcturus Therapeutics shares fell 18.24% to $34.83, with a market cap of $938.0 million.
The significant price decline indicates negative sentiment or adverse news impacting the stock.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Biomea Fusion stock declined by 63.1% to $4.16, with a market cap of $149.5 million.
The significant price decline suggests negative sentiment or adverse news impacting the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Concord Medical Services stock declined by 20.08% to $0.78, with a market cap of $33.6 million.
The price decline suggests negative investor sentiment or news.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Seres Therapeutics stock declined by 22.64% to $0.66, with a market cap of $99.9 million.
The notable price decline suggests negative investor sentiment or news.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
ENDRA Life Sciences stock declined by 17.7% to $0.09, with a market value of $1.6 million.
The price decline suggests negative investor sentiment or news.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Scinai Immunotherapeutics shares declined by 32.02% to $2.82, with a market value of $1.6 million.
The substantial price decline indicates negative market reaction, possibly due to unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100